URS
CORT icon

Utah Retirement Systems’s Corcept Therapeutics CORT Stock Holding History

Utah Retirement Systems’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Buy
+4,968
New +$186K ﹤0.01% 953
2025
Q4 		– Sell
-4,968
Closed -$413K – 986
2025
Q3 		$413K Hold
4,968
– – ﹤0.01% 786
2025
Q2 		$365K Buy
+4,968
New +$360K ﹤0.01% 825

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Utah Retirement Systems's CORT Position: Q1 2026 in Review

Utah Retirement Systems opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 4,968 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #953 among its holdings. This is a return to the name: Utah Retirement Systems previously reported a position in CORT as recently as Q3 2025.

Utah Retirement Systems first reported a position in CORT in Q2 2025 and has held it in 3 quarters since. The position peaked at $413K in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Utah Retirement Systems held 4,968 shares of Corcept Therapeutics worth $200K as of Q1 2026.
  • Corcept Therapeutics was a new Utah Retirement Systems position in Q1 2026.
  • Corcept Therapeutics made up ﹤0.01% of Utah Retirement Systems's portfolio in Q1 2026, its #953 holding.
  • Utah Retirement Systems first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Utah Retirement Systems's Corcept Therapeutics position peaked at $413K in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.